Skip to content

Clinical trials

Recruiting Atypical Hemolytic Uremic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atypical Hemolytic Uremic Syndrome Status: Recruiting Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20131
20211
20232
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.3
Mario Negri Institute for Pharmacological Research2
Novartis Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Maastricht University Medical Center1
Sanford Health1
UK Kidney Association1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atypical Hemolytic Uremic Syndrome12
Thrombotic Microangiopathies4
Glomerulonephritis, Membranoproliferative3
Cystinosis2
Denys-Drash Syndrome2
Myasthenia Gravis2
Oculocerebrorenal Syndrome2
Polycystic Kidney, Autosomal Dominant2
Acute Kidney Injury1
Addison Disease1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.